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The designation "fixed drug eruption" was
probably first used by Broeq (1), whose descrip-
tion may be briefly summarized as follows:
Dusky red, later brownish plaques, with
well-defined borders, and edematous or bullous
centers, tending to recur at precisely the same
site, leaving brown pigmented patches on healing.
The following drugs have been found to
produce this type of reaction (2, 3):
Acetanilid lodides
Acetophenetidin Ipecac
kminopyrine Para-aminosalicylic acid
Antimony salts Penicillin
Arsenicals Phenolphthalein*
Chlorotetracyeline Quinacrine
Barbiturates* Quinidine
Bismuth Quinine
Cinehophen Salicylates
Emetine Sulfonamides
Gold salts Oxytetraeyeline
Antihistamine drugs have been reported to
cause a large variety of cutaneous manifesta-
tions (4), but none have hitherto been reported
as the cause of a fixed eruption. For the past
three years we have been studying a patient
with a fixed eruption caused by Dramamine®.
CASE REPORT
FE., 57, female, married, owner of a telephone
answering service, complained of recurrent,
brownish areas on the right thigh, leg and foot
for several years. At irregular periods, precisely
the same areas would become itchy, occasionally
blistered; and this would slowly subside to leave
round, brownish patches of varying intensity
(Figs. 1 and 2). She had frequent headaches,
for which she took a large number of medications
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* Most frequently induce fixed eruptions.
containing salicylates, caffeine, and aceto-
phenetidin. She denied taking barbiturates,
phenolphthalein-containing medications or
sulfonamides, or any of the remainder of the
drugs listed above as causing fixed eruptions.
There apparently was no relation between the
flares in the fixed eruption and the headache
remedies, since these were taken frequently,
in large quantities, but the flares were few and
far between.
In April 1955 she developed herpes zoster
ophthalmicus of the left eye. This healed in six
weeks. On May 2, 1955 she took an aspirin
tablet. There was no effect on the eruption. On
May 5th she took two tablets containing caffeine,
aeetophenetidin and aspirin, with no change in
the eruption. Barbiturates, sulfonamides,
amphetamine containing reducing remedies,
phenolphthalein, and quinine containing drinks
all failed to influence the brown patches. Finally
she had a flare of the eruption shortly after re-
turning from a trip to Florida. The possibility
that it was caused by Dramamine® taken to
prevent motion sickness was considered, and as
soon as the acute process subsided she was
asked to take one Dramamine® tablet. The next
morning each pigmented area flared (Figs. 3 & 4)
with increased swelling and inflammatory halo,
followed by deepened pigmentation. The re-
action subsided in two weeks, leaving brown, well-
defined, discoid patches on the thigh and foot.
These faded slowly, but did not disappear.
Several blood counts revealed a red cell count
varying between 3.5 and 4.2 million, with
hemoglobin ranging between 11 and 13 grams.
The white cell count was normal, with a normal
differential. Other laboratory studies, including
serologic tests for syphilis, total protein and
A/G ratio, urea nitrogen, uric acid, and liver
function tests, were all within normal limits.
CLINICAL STUDIES TO DETERMINE REACTIVE
CHEMICAL GROUP
Dramamine® is a combination of diphen-
hydramine (Benadryl®) and S-chlorotheophylline
(hereon designated S-CT), which have the
chemical structures shown in Fig. 5.
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FIG. 1: Pigmented area on posterior aspects of
thigh during quiescent phase. Note variation in
intensity of pigmentation, and absence of inflam-
matory halo.
FIG. 2: Barely perceptible, slightly scaly and
pigmented area on inner aspect of right foot,
during quiescent phase.
Since there was no cutaneous reaction to
Benadryl®, the patient was given 10 mg. of
8-CT; there was a prompt and striking flare
(Fig. 4).
The evolution of the fixed drug eruption oc-
curred as follows: Fifteen hours after ingestion
of 10 mg. of 8-CT there was itching at the
fixed reaction sites; at 16 hours a ring of erythema
was noted around the pigmented patch; by 20
hours edema appeared, and in 22 hours a flat,
superficial bulla developed. The bulla slowly
increased in size, and pigmentation deepened.
FIG. 3: Inflammatory halo about pigmented
site on thigh, 48 hours following ingestion of 25
mg. of Dramamine®. An identical flare occurred
following the ingestion of 10 mg. of 8-ehlorotheo-
phylline, but not when diphenhydramine was
taken.
FIG. 4: Increased pigmentation, sealing, and
inflammatory halo about pigmented site on right
foot, following ingestion of Dramamine® or 8—
ehlorotheophylline.
Crusting slowly appeared and then disappeared
over a period of 2 to 3 weeks, leaving the usual
hyperpigmentation at the site.
8-Chlorotheophylline is a xanthine derivative.
The interrelationship between certain xanthinea
is illustrated in Fig. 6.
There was no reaction to unmodified theophyl-
line, theobromine or caffeine, so that evidently
the chlorine atom was necessary to provoke the
reaction.
a
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Diphenhydramine (Benadryl®) Xanthine
H—N,—C6=0
0113 H/ /CH—0—0113—CH2TN 0=01 C5—N7
CH3 >Cs_H/
8_ehlorotheophylline* Theophylline
CHS—N(fl—C(i)=0 C113—N-—C=0H H
0(l)—C(l)—N O=C
-
L - )C(s)-Cl -
-i )C-HOH3 (3) (4) N CR3 N C N
* B -dimethylaminoethyl -benzohydryl ether -8- 1,3 dimethyixanthine
chiorotheophyllinate. Theobromine
FIG. 5 H—N—0=0
CR3
Could theophylline substituted with other o= C—Ni
halogens produce the fixed reaction? Iodine and
fluorine compounds were not available but
• . CH,—N—C----N8-bromotheopbylhne in a dose of 10 mg. caused
precisely the same reaction as 8-CT. 3,7 dimethyixanthine
Was it essential that the halogen be in the Caffeine
S position? It seems that the only atom available CHI—N—C==0for substitution in theophylline is carbon S. OH3
Carbon 2 and 6 contain the keto group, and N"
nitrogen atoms 1 and 3 a methyl group, leaving
—
1
—
one nitrogen atom and carbon 8. Since the halo-
amines are not stable, the halogen cannot be CH3N —N
substituted in any position other than carbon 8. 1,3,7 trimethylxanthine
Other halogenated xanthines were not available, 8—cblorotheophylline
so we do not know if a halogenated theobromine H N
or caffeine would be reactive. C —0=0 H
The question then arose whether she was /
sensitive to other antihistamine drugs. She was 0=0
given commonly prescribed doses of the following CCl
drugs: CH3—N—C—N
1,3 dimethyl 8-ehioroxanthine
Benadryl® (Parke, Davis)
Bonamine (Pfizer) FIG. 6
Chlor-Trimeton® (Schering)
Clistin® (McNeil) she became dizzy and developed twitching of the
Co-Pyronil® (Lilly) face and extremities, but this subsided promptly.
Histadyl® (Lilly) The other medications produced no effect other
Marezine® (Burrooghs-Wellcome) than drowsiness and dryness of the mouth.
Neo-Antergan® (Merck, Sharp & Dohme)
Perazil® (Burroughs-Welleome) ATTEMPTS TO SUPPRESS nEAc'rroN
Phenergan® (Wyeth)
Pyribenzamine® (Ciba) Since this remarkably cooperative patient
Thephorin® (Hoffmann-La Roche) made many air trips for which she required an
anti-motion-sickness remedy, an attempt was
None of these had any effect on the eruption. made to suppress the fixed reaction. As noted
Following the ingestion of 25 mg. of Benadryl,® above the patient had a systemic, probably
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central nervous system, reaction to the diphen-
hydramine portion of the Dramamine® molecule,
but this was suppressed, or prevented, by the
complete compound. However, the antihistamine
Benadryl® did not prevent the 8-CT from pro-
ducing a fixed drug eruption. The possibility
arose that the fixed reaction could be suppressed
or prevented by other antihistamine drugs.
Accordingly, over a six month period, all 12 of
the drugs listed in the case report were given in
full doses for one day before taking 10 mg. of
8-CT, the day it was taken, and for 5 days after-
wards. There was no effect on the time of onset,
the severity of reaction or its duration.
In the attempt to suppress the drug eruption,
80 mg. of hydroeortisone or its equivalent as
prednisone or prednisolone were given. Here the
intensity of the reaction was somewhat dimin-
ished but, time of onset and duration unchanged.
The result was practically identical when ACTH,
in a gelatin vehicle, was given in a dose of 80 units
the day of administration, and 40 units daily
thereafter, for 5 days.
It must be noted that this patient was de-
liberately exposed to the causative antigen at
least 20 times, over a period of three years, yet
she reacted just as vigorously at the end of this
long period as she did at the beginning. This indi-
cates quite clearly that there is little or no tend-
ency for a patient to lose his sensitivity to a fixed
drug antigen following repeated exposures over
a long period of time; at least this is true in the
ease of this patient and this antigen, 8-chloro-
theophylline. During a six month period this
patient was re-exposed to this antigen 12 times
at two week intervals, with not the slightest
evidence of any tendency toward local or general
desensitization or exhaustion of the reaction.
The reaction remained exquisitely specific
throughout the long period of study (21).
ATTEMPTS AT LOCALIZING TRE sMOCK TIssUE
Attempts to determine the shock tissue in the
fixed reaction have been made by others chiefly
by transplantation experiments. Results have
been inconclusive, but the current tendency is
to localize the reaction in the deeper blood vessels,
and to consider that it is then reflected like a
cone toward the surface, to appear as a discoid
plaque.
An attempt was made to study the vascular
pattern at the reaction site by intravenous injee-
tion of sodium fluorescein followed by visualiza-
tion under Wood's light. A quiescent patch shows
no fluorescence. An activated patch, however,
shows an intense ring of greenish fluorescence
with a dark, central zone. The fluorescent ring
marks the site of the inflammatory halo. The
central edematous or bullous area develops
fluorescence somewhat later, a fluorescence partly
masked by the pigmentation. This fluorescence
fades gradually over a 10—14 day period and then
disappears; while its onset coincides with, or
slightly precedes, the clinical flare. Based on
other observations, this vascular ring, in all
probability, consists chiefly of capillaries in the
papillary zone, and may represent at least a
portion of the shock tissue.
If the superficial capillary loops are the shock
tissue, they may be accessible via the epieu-
taneous route, and a fixed reaction may then be
obtainable by patch testing the previously reac-
tive site. Accordingly, a patch test with powdered
8-CT was applied to the pigmented area on the
right thigh for 48 hours. A control patch test was
applied with plain, i.e., non-halogenated theo-
phyllin powder to the pigmented lesion on the
right foot. When the patches were removed in
48 hours, there was a moderate, fixed drug reac-
tion with itching, edema, erythema and increased
pigmentation on the thigh (Figs. 7 & 8) with no
reaction on the foot. This same phenomenon
was noted by Loveman (5) in his work on a fixed
reaction caused by a barbiturate. Peck (6), in
discussing Loveman's paper, suggested that this
might best be called a Moro patch test, analogous
to the Moro tuberculin test. It suggests that the
shock tissue is readily accessible to the antigen
via the epicutaneous route, and fits in with the
concept that the superficial dermal vessels are at
least part of the shock tissue. It also suggests
that the antigen becomes complete in its passage
through the epidermis and/or the adnexae, and
does not require passage through the gastro-
intestinal tract before being able to unite with
its antibody.
Derbes (7) has also obtained positive patch
test reactions limited to the fixed reaction site
with aminopyrine. We believe the patch test
with the suspected material at a quiescent fixed
eruption site is a useful diagnostic procedure for
this type of drug eruption, without the potentially
dangerous sequelae inherent in testing the sus-
pected drug by mouth or by injection. As with
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Fin. 7: Pigmented area, right thigh, just before
application of patch test with 8-chlorotheophyl-
line.
so many other tests, a negative reaction has little
significance. It must be emphasized, however,
that a positive reaction must reproduce the fixed
drug reaction to be considered diagnostic. An
eczcmatous or follicular response must be con-
sidered lacking diagnostic significance.
This is in contrast to results with patch testing
in fixed reactions due to phenolphthalein, which,
according to Bacr (8) and the experience of the
senior author, are negative. It is possible that
phenolphthalein requires modification by passage
through the gastro-intestinal tract and/or liver
before it can become a complete antigen and
unite with antibody to provoke a fixed drug
reaction.
ADDITIONAL STUDIES
Following the intracutaneous injection of
0.1 cc of parenteral solution of Dramamine® into
the center of the fixed reaction site on the right
thigh, there was a sharp local flare with a periph-
eral zone of erythema and edema and deepening
of the pigmentation within twelve hours, fol-
lowed by a flare at previously involved sites on
the foot and leg during the ensuing 12 hours. A
control injection on the opposite thigh caused no
local reaction other than a small slough, but did
Fin. 8: Same area following removal of patch
test with crystals of 8-chlorotheophylline applied
to pigmented area for 48 hours. Note the bulla in
the center, the increased pigmentation and inflam-
matory halo—a fixed drug reaction, not an ecze-
matous reaction, to the patch test.
cause a moderate flare at all previously affected
areas within 24 hours.
When this reaction subsided, 0.1 cc of a 0.5%
suspension of 8-CT in water was injected into
the fixed reaction site on the right foot. A mild
local flare appeared, but other previously affected
areas did not react. A similar injection on the
other foot caused no reaction. Evidently there
was little or no systemic absorption, probably
because 8-CT is extremely insoluble in water.
HISTOLOGIC AND m5T0cHEMICAL sTuDIES
Technic:
Under local xylocainc anesthesia biopsy speci-
mens were removed (1) from the central bulla of
the fixed drug eruption, (2) from the periphery
of the lesion which clinically showed only ery-
thcma, and (3) from a normal skin site nearby.
All three biopsies were performed at the same
sitting, 48 hours after the administration of the
allergen and 26 hours after the appearance of the
bulla (see page 4).
The biopsy specimens were fixed in 95% alcohol
(24 hours), absolute alcohol (24 hours), chloroform
(2 hours); embedded under vacuum in paraffin;
and serially sectioned at 4 microns.
-
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FIG. 9: Specimen from central bulla of the fixed drug eruption showing exocytosis, spongiosis, exo-
serosis, and reticular degeneration of epidermal cells in the sides and roof of the subepidermal bulla.
Note denuded papillae at left (arrow) and perivascular inflammatory infiltrate in cutis. Hematoxylin-
eosin stain. X66.
The following stains were employed:
1. ilematoxylin and Eosin (aqueous, at ph.
6.0)
2. Toluidine Blue (at ph. 3.7)
3. Giemsa
4. Carmine
5. Hotchkiss-McManus including diastasc
digested controls for glycogen
6. Masson Trichrome
7. Orcein
8. Fontana (silver)
9. Alkaline Phosphatasc (Comori)
10. Alcian Blue—Periodic Acid Schiff
11. Perl
Findings: The essential histologic findings were:
A) Changes in the Epidermis
1) bulta formation associated with reticular
degeneration of the epidermal cells in
the wall of the bulla.
2) a process of premature teeratinization of
epidermal cells both of scattered individ-
ual cells and of groups of cells.
B) Changes in the Cutis
1) a primarily perivascular banal inflamma-
tory infiltrate in the upper cutis associated
with pronounced edema.
A. Epidermal changes:
1. Subepidermat bulla formation—In the biopsy
specimen taken from the central area of the
lesion, the epidermis showed cxocytosis, exosero-
sis and the formation of a subepidermal bulla
(Fig. 9). The contents of the hulla was composed
of mostly serum, a few leukocytes (polymorpho-
nuclear lcukocytes, lymphocytes, but no eosino-
philes) and the remnants of necrotic epidermal
cells. The cpidermal cells of the walls of the bulla
had undergone reticular degeneration (so that
only their cell membranes remained in web-like
networks). The dermal papillae which projected
into the floor of the bulla were either completely
denuded or were covered only by a few clusters
of epidermal cells. There was no acantholysis or
segregation of isolated cpidermal cells. In some
denuded areas on the floor of the bulla the base-
ment membrane lining the papillae had been
destroyed. The roof of the bulla consisted of epi-
dermal cells with marked intracellular edema and
nuclear abnormalities (pyknosis, crenation, con-
densation). In the bulla roof parakeratosis was
apparent only in the lowermost horny layer. The
44-
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FIG. 10: Specimen from periphery of lesion showing prematurely keratinized epidermal cells (arrow)
in continuity with overlying stratum cornenm. Some nuclei have been retained in this keratin pearl.
Giemsa stain. 1<156.
abscnce of parakcratotic cells in the more super-
ficial portions of the stratum corneum is indica-
tive of the abruptness of the process so that
parakeratosis has not yet reached the surface.
The epidermal cells neighboring the bulla have
an accumulation of intracytoplasmic glycogen
as might be anticipated in such damaged cells.
2. Premature keratinization—A striking feature
which was most evident in the specimen taken
from the periphery of the lesion (and absent in
the normal skin specimen) was that of a process
of premature keratinization of the epidermal cells.
Although this process was found occasionally in
an isolated epidermal cell it more commonly was
seen in well localized groups of epidermal cells
which resulted in formation of keratin pearls.
These cell-nests of prematurely keratinized cells
were seen predominantly in the upper one-half
of the epidermis and on serial sections usually
were found to be in direct continuity with the
overlying stratum corneum so that they gave the
appearance of horny invaginations of the stratum
corneum into the epidermis (Fig. 10). The process
of premature keratinization was also found in
deep seated isolated epidermal "keratin pearls"
not attached to the overlying horny layer
(Fig. 11). Many "keratin pearls" were composed
of a central refringent amorphous material which
had all the special staining characteristics of the
horny layer. At times nuclei were retained in this
refringent material. A flattened layer of cells
filled with keratohyalin granules surrounded this
central horny material.
With the special stains employed the staining
characteristics of the keratin pearls resembled those
of the normal stratum corneum and "stratum
lucidium". Hematoxylin and eosin stained the
normal horny layer and the keratin pearls a
brilliant refractile homogeneous pinkish-red.
However, other elements in the epidermis such
as the necrotic cells in the bulla wall and lakes of
serum stained similarly. It was only after other
stains were employed that it became obvious
that the staining characteristics of the keratin
pearls were consistently identical to those of the
normal horny layer and differed from the necrotic
epidermal cells which lined the bulla. Therefore,
the two processes, i.e., spongiosis with bulla
formation and premature keratinization, ap-
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Fjo. 11: Specimen from periphery of lesion with several groups (arrows) of nucleated prekeratinized
epidermal cells. Hematoxylin-cosin stain. X375.
peared to occur simultaneously iu different areas
of the epidermis.
With toluidine blue the normal stratum cor-
neum was stained greenish-blue whereas the
normal "stratum lucidum" remained unstained.
Similarly the keratin pearls had greenish-blue
centers surrounded by an unstained halo. Giem.sa
colored the normal stratum corneum and the
central portions of the keratin pearls bright blue.
With lithium carmine one again found all the
elements of the normal epidermis reconstructed
in the pearls since on the one hand the upper
horny layer of the normal skin specimen and
centers of the prematurely keratinized pearls
were light pink, whereas on the other haud, the
lower horny layer ("stratum lucidum") of the
normal specimen and the peripheral portions of
the keratin pearls stained dark pink.
A remarkable feature of these groups of pre-
maturely keratinized cells was that they con-
tained large quantities of melanin (Fig. 12)
whereas it was present in relatively small quantity
in the surrounding epidermis (Fontana stain).
B. Changes in the eutis in the specimen taken from
the central bulla:
The most prominent changes were seen in the
uppermost cutis and progressively lessened in
its depth. In the papillary bodies and upper one-
half of the cutis there was amassive essentially
perivascular inflammatory infiltrate composed
principally of small round cells and histocytes.
Very few polymorphonuclear lcukocytcs were
seen in this infiltrate. There appeared to be a
slight increase in the number of mast cells in
comparison with the normal control specimen.
Remarkably, only a rare cosinophile was seen in
the dermal cellular infiltrate.
The adnexae which consisted of a few hair
follicles and eccrine sweat glands appeared rela-
tively unaffected by the intense reaction higher
in the cutis. However, some eccrinc sweat glands
showed vacnolization of the cells lining the acini
while others had dilated lumens. These findings
were presumably the result of back pressure on
the sweat glands caused by mechanical obstruc-
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FTG. 12: Specimen from periphery of lesion stained with Fontana silver stain illustrating numerou
melanin granules within the kerntin pearls (arrows) in contrast to the relative sparsity of granules in
the nearhy epidermal cells. x375.
tion of their ducts by the pathologic processes
which had taken place in the upper cutis and
epidermis.
Other stains of sections taken from the speci-
men removed from the central bulla included:
1. Masson Trichrome—the collagen fibers in
thc upper cutis were separated and pushed aside
by the edema and inflammatory cellular infiltrate
but were otherwise unaltered.
2. Alkaline Phosphatase—many of the fine
capillaries in the upper and mid-cutis were easily
identified in the massive inflammatory reaction
by their strong alkaline phosphatase activity per-
mitting one to establish the dilatation of the
capillaries and primarily perivascular localization
of the inflammatory infiltrate. Some inflam-
matory cells nearest the vascular walls had alka-
line phosphatase activity although those farther
away showed none. Those findings are probably
due to diffusion of the enzyme. An abnormal
feature was the presence of a number of dilated
thin walled vessels in the upper cutis (dilated
capillaries or lymphatic channels) with absence of
alkaline phosphatase activity. Well below the
massive inflammatory infiltrate of the upper
cutis, there was a wide band-like zone of alkaline
phosphatase activity in the cutis and subeutis
which was found in relation to: the small blood
vessel walls, the sparse perivascular inflammatory
infiltrate, the eccrine sweat glands and the
"ground substance" interspersed between the
collagen bundles.
3. Orcein—the elastic fibers were dissociated
in areas of marked edema and inflammatory
infiltrate.
4. Toluicline Blue—a deposit of fine filaments
of metachromatic material was seen between the
connective tissue fibers throughout the cutis.
This material stained purplish with Giemsa,
magenta with llotchkiss-MeManus (both di-
gested and undigested), and light greenish-blue
with PAS-Alcian Blue. All these stains suggest
that the metaehromatic material between the
collagen bundles is mucin or a mucoid material.
No similar mucoid material was evident in the
normal skin specimen.
.
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DISCUSSION
It is apparent that this patient has a fixed drug
eruption due to the 8-ehlorotheophylline fraction
of Dramamine®, and that a halogen must be
present in the molecule to evoke the reaction.
The fluorescence of the erythematous halo
following intravenous administration of sodium
fiuorcsccin beginning with the onset of the clini-
cal reaction to the drug may be interpreted as
indicating injury and increased permeability of
the capillaries at that site (9), and suggests the
capillary wall as being at least part of the shock
tissue. The occurrence of a fixed drug reaction to
patch tests with 8-CT at a reactive site suggests
that the shock tissue is available to the antigen
via the epicutaneous route, and also fits in with
the superficial vessels as possible shock tissue
sites. It is clear, too, that 8-CT is, or can become,
a complete antigen via the epicutaneous route
as well as via the gastro-intcstinal tract. This is
not true of some other drugs causing fixed drug
eruptions. Specifically, phenolphthalcin, accord-
ing to Bacr, and in the experience of one of us
(CS.) does not produce a reaction on patch test-
ing over the site of the fiaed eruption.
There have been a number of transplantation
experiments designed to clarify the site of the
shock tissue, some of which show that the fixed
area of sensitivity can be moved from one area
to another by transplantation of full-thickness
grafts (10, 11), while others show that the skin
of fixed eruption areas when transplanted to
normal areas react at first, but later fail to react;
while the normal skin transplanted to the fixed
eruption site later becomes reactive (12, 13, 14).
The first group of experiments fit in with the
concept that the superficial blood vessels are the
shock tissue (or part of it). The second group of
experiments suggests that the shock tissue resides
in the deeper vessels. It may also be interpreted,
however, to mean that the newly transplanted
capillaries require time for them to develop the
characteristics necessary to become reactive, or
that new formed capillaries, later developing at
this site, become reactive, somehow, from the
surrounding milieu.
Failure to inhibit the reaction with most of the
available antihistamine drugs suggests that
histamine does not play an important role in the
mechanism of the reaction. The slight suppres-
sion with ACTH or steroids is probably merely a
manifestation of local inhibition of full inflamma-
tory response to the antigen-antibody reaction.
The histologic findings demonstrate that two
distinct processes were taking place in the epi-
dermis at the time that the biopsy specimens were
obtained. The first was a massive intra- and
intercellular edema, necrosis of epidermal cells
and the formation of a primarily subepidermal
bulla. The second process was one of premature
keratinization of individual or groups of epi-
dermal cells (pearls) in the stratum spinosum.
Hematoxylin and eosin stains revealed the pres-
ence of a refractile bright pink-red substance
within the cytoplasm of the cells composing these
pearls which had all the special staining char-
acteristics of keratin. There is no apparent rela-
tionship between the formation of the bulla and
these peculiar prematurely keratinized cells and
serial sections did not suggest that one gave rise
to the other. The occasional presence of such
prematurely keratinizcd cells adjacent to the
bulla appears to be a chance finding (Fig. 13).
It is debatable whether the histologic findings
of premature kcratinization in the specimens
taken from our patient can be called dyskeratosis.
Civatte (18) mentions in antipyrine fixed drug
eruptions the finding of scattered bizarre and
mitotic Malpighian cells which suggested certain
precancerous dyskeratoses. Although these pre-
cise features were not seen in the patient herein
reported, it is nonetheless interesting to note that
Civatte likened his findings to the dyskeratoses.
If one understands dyskeratosis to mean a proc-
ess in which epidermal cells undergo keratiniza-
tion to form special types of cells (grains and
corps ronds) which become segregated from the
surrounding epidermal cells, the process occurring
in our patient with fixed drug eruption is not one
of dyskeratosis since none of these features were
found. On the other hand, if one considers dys-
keratosis to include all pathologic processes in
which cpidcrmal cells keratinize at the wrong
time and in the wrong place while still in the
epidermis (14), then the term dyskcratosis would
apply to the events which have taken place.
From these studies, the only apparent feature of
the keratin pearls seen in these specimens which
is abnormal is the fact that the cells were under-
going keratinization in an accelerated fashion
at a site deeper in the epidermis than one finds in
normal skin. However, as far as one could tell the
process of kcratinization which resulted in the
formation of the keratin pearls appears to include
all the successive stages which are found in
normal kcratinization (stratum spinosum—
stratum granulosum—' 'stratum lucidum' '—stra-
turn corneurn). Because of the controversy we
prefer to call the changes occurring in this speci-
men premature keratinization.
We have not come across other reports of
similar observations which may mean that this
process of premature keratinization is unique in
our patient or that it had escaped the attention
of others since in our case special stains were
required to clarify the findings on routine hema-
toxylin-eosin stain. It is suggested that selected
stains be employed on biopsy material from
other patients with fixed drug eruptions, to deter-
mine if similar events take place.
Another possibility which exists is that this
peculiar process of premature keratinization
existed at the site of the fixed reaction prior to the
administration of the allergen. This may be of
more than academic interest since such a pre-
existing alteration may be a factor in the fixation
of the eruption to a site. Although not confirmed
by others (14, 15) some workers (10, 12) have
shown that sites susceptible to fixed drug erup-
tions when transplanted to other areas in the
same person retain their sensitivity at least for
some period of time. Furthermore, Naegeli et al
(10) have shown that skin removed from the
site of a recently healed antipyrine fixed drug
eruption when immersed in a 10% solution of
antipyrine in vitro underwent marked epidermal
(vesicular) and dermal (vascular dilatation,
edema) changes, whereas normal skin taken from
the same patient failed to show any such changes
when immersed in the same solution for a similar
length of time. These previous observations as
well as our own suggest that detailed study of
areas susceptible to fixed drug eruptions com-
pared with neighboring normal skin should be
carried out in the attempt to uncover chemical,
anatomical, histochemical, or other differences
which may explain the peculiarity of such fixed
localizations.
A striking feature of the prematurely kcratin-
ized groups of epidermal cells was the findings of
numerous melanin granules scattered throughout
the keratin pearls when compared with the rela-
tively few melanin granules visible in the sur-
rounding unaffected epidermal cells. It remains
to be determined what role, if any, melanin
concentrated within these prematurely keratin-
ized cells plays in the hyperpigmentation which
so characteristically follows fixed drug eruptions.
Previous workers (10, 12) have reported that in
fixed drug eruptions manifesting hyperpigmenta-
tion melanin is found in excess in the basal layer
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FIG. 13: This specimen from the bulla periphery has a small group of prekeratinized epidermal cells
near its edge (arrow). Giemsa stain. X186.
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and in the upper eutis (predominantly within
melanophages). The biopsy specimens from the
lesion site in our patient did not show increased
melanin in these sites when compared with the
specimen taken from normal skin. However, the
accumulation of melanin in the basal layer and
upper cutis reported by others may not make its
appearance until a later stage in the evolution
of such lesions.
The findings within the dermis consisting of
vascular dilation, marked edema and primarily
perivaseular cellular infiltration is consistent
with the observations of others (10, 11, 14). The
lack of alkaline phosphatase activity of some of
the superficial capillaries is distinctly abnormal
and an unusual finding in skin disease (15). The
presence of a mucoid substance in the eutis can
he seen in other inflammatory conditions involv-
ing the eutis.
SUMMARY AND CONCLUSIONS
1. A patient with a fixed drug eruption caused
by 8-ehlorotheophylline in Dramamine® is re-
ported. This is believed to be the first such ease
recorded in the literature.
2. The identical reaction occurred with S-bro-
motheophylline, but no reaction occurred to
theophylline per se or to related xanthine deriva-
tives, such as theobromine or caffeine.
3. There was no suppression of the reaction
by the conjoint use of many different anti-
histamine drugs, and only minimal suppression
from ACTH or corticosteroids.
4. Evidence is presented suggesting that at
least part of the shock tissue resides in the
superficial dermal blood vessels.
5. The histologic findings included a massive
edema and primarily perivascular inflammatory
infiltrate in the eutis. Epidermal changes con-
sisted of 1) spongiosis, exoserosiS and exocktosis
with bulla formation and 2) an unusual process
of premature keratinization in which single or
groups of epidermal cells underwent keratiniza-
tion in the form of keratin pearls within the
stratum SpinoSum.
6. A fixed drug reaction limited to the pig-
mented site was produced by a 48—hour occlusive
patch test with the suspected drug. It is sug-
gested that this constitutes a useful and harmless
diagnostic procedure for determining the causa-
tive agent in fixed drug eruptions:)
We wish to express our sincere thanks to Dr.
Sonia D. Morrill for her valuable suggestions
and review of the pathological and histoehemical
material.
We wish to express our appreciation to G. D.
Searle & Co., for providing us with much of the
material for this study.
This ease was presented before the Bronx
Dermatological Society, March 15, 1956, and
published in its Transactions, A. M. A. Arch.
Dermat. & Syph. 75: 283, Feb. 1957.
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